• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估DNA甲基化谱在骨源性肌源性肉瘤分类中的效用。

Assessing the Utility of DNA Methylation Profiling in the Classification of Myogenic Sarcomas of Bone.

作者信息

Bandhlish Anshu, Liu Yajuan J, Fang He, Gandhi Jatin, Paulson Vera, Chen Eleanor Y

机构信息

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.

出版信息

Int J Surg Pathol. 2025 Jan 7:10668969241300497. doi: 10.1177/10668969241300497.

DOI:10.1177/10668969241300497
PMID:39763459
Abstract

The diagnosis of primary leiomyosarcoma (LMS) of bone is generally established based on integrative findings of morphologic features, immunohistochemical staining, and clinical and radiological findings. There are no specific genetic alterations that can be used to confirm the diagnosis of LMS in challenging diagnoses of bone sarcomas with myogenic differentiation. In this study, we assessed the utility of a DNA methylation-based classifier as an ancillary diagnostic tool for subclassifying bone sarcomas with myogenic differentiation. DNA methylation profiling using the Deutsches Krebsforschungszentrum classifier system was performed on 5 patients with available formalin-fixed paraffin-embedded tissue blocks. The original diagnosis of LMS was retained in 2 of 5 patients. Three patients were reclassified as having malignant giant cell tumor of the bone, malignant peripheral nerve sheath tumor, or undifferentiated pleomorphic sarcoma/myxofibrosarcoma after integrating the results of the DNA methylation-based classifier with the clinicopathologic, immunohistochemical, and radiologic findings. While a DNA methylation-based classifier can serve as a useful ancillary tool for refining the subclassification of primary bone sarcomas with myogenic differentiation, especially for diagnostically challenging tumors, integrating clinical, histopathological, and radiological findings is essential for obtaining a final diagnosis.

摘要

骨原发性平滑肌肉瘤(LMS)的诊断通常基于形态学特征、免疫组化染色以及临床和影像学检查结果的综合判断。在具有肌源性分化的骨肉瘤诊断存在挑战时,尚无特定的基因改变可用于确诊LMS。在本研究中,我们评估了基于DNA甲基化的分类器作为辅助诊断工具对具有肌源性分化的骨肉瘤进行亚分类的效用。使用德国癌症研究中心分类系统对5例有可用福尔马林固定石蜡包埋组织块的患者进行了DNA甲基化分析。5例患者中有2例维持原LMS诊断。将基于DNA甲基化的分类器结果与临床病理、免疫组化和影像学检查结果相结合后,3例患者被重新分类为骨恶性巨细胞瘤、恶性外周神经鞘瘤或未分化多形性肉瘤/黏液纤维肉瘤。虽然基于DNA甲基化的分类器可作为有用的辅助工具,用于完善具有肌源性分化的原发性骨肉瘤的亚分类,尤其是对于诊断具有挑战性的肿瘤,但综合临床、组织病理学和影像学检查结果对于获得最终诊断至关重要。

相似文献

1
Assessing the Utility of DNA Methylation Profiling in the Classification of Myogenic Sarcomas of Bone.评估DNA甲基化谱在骨源性肌源性肉瘤分类中的效用。
Int J Surg Pathol. 2025 Jan 7:10668969241300497. doi: 10.1177/10668969241300497.
2
Classification of pediatric soft and bone sarcomas using DNA methylation-based profiling.基于 DNA 甲基化分析的儿科软组织和骨肉瘤分类。
BMC Cancer. 2024 Nov 20;24(1):1428. doi: 10.1186/s12885-024-13159-9.
3
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
4
Classification of Fibro-Osseous Tumors in the Craniofacial Bones Using DNA Methylation and Copy Number Alterations.利用DNA甲基化和拷贝数改变对头面部骨纤维骨性肿瘤进行分类
Mod Pathol. 2025 Jun;38(6):100717. doi: 10.1016/j.modpat.2025.100717. Epub 2025 Jan 23.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.全面的突变分析确定了皮肤平滑肌肉瘤中的新驱动事件。
Br J Dermatol. 2025 Jan 24;192(2):335-343. doi: 10.1093/bjd/ljae386.
7
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
8
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Pulp treatment for extensive decay in primary teeth.乳牙大面积龋坏的牙髓治疗
Cochrane Database Syst Rev. 2018 May 31;5(5):CD003220. doi: 10.1002/14651858.CD003220.pub3.